Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.

about

Genomic analysis and clinical management of adolescent cutaneous melanoma.

P2860

Q33701435-61AF6B35-838A-4475-92D7-02D108554DE7

P2860

Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.

Item

http://www.wikidata.org/entity/Q39755837

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Varying proliferative and clon ...... ocytic nevi according to size.

@en

Varying proliferative and clon ...... ocytic nevi according to size.

@nl

type

Item

label

Varying proliferative and clon ...... ocytic nevi according to size.

@en

Varying proliferative and clon ...... ocytic nevi according to size.

@nl

prefLabel

Varying proliferative and clon ...... ocytic nevi according to size.

@en

Varying proliferative and clon ...... ocytic nevi according to size.

@nl

P1476

Varying proliferative and clon ...... ocytic nevi according to size.

@en

P2093

Alexandre How-Kit

http://www.w3.org/2001/XMLSchema#string

Arnaud Picard

http://www.w3.org/2001/XMLSchema#string

Aurore Coulomb-L'Hermine

http://www.w3.org/2001/XMLSchema#string

Christelle Charbel

http://www.w3.org/2001/XMLSchema#string

Natacha Kadlub

http://www.w3.org/2001/XMLSchema#string

Sylvie Fraitag

http://www.w3.org/2001/XMLSchema#string

Thomas Rouillé

http://www.w3.org/2001/XMLSchema#string

P2860

Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies

Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease

Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.

High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi.

Melanoma risk in congenital melanocytic naevi: a systematic review.

Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.

New recommendations for the categorization of cutaneous features of congenital melanocytic nevi.

Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies.

Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development.

Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS

P304

789-796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EXD.13073

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Selim Aractingi

Sarah Guegan

Romain H Fontaine

P577

2016-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27193390

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.

about

P2860

P2860

Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921